Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kirk Beebe

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Science (New York, N.Y.)|August 8, 2009
The C-Ala domain brings together editing and aminoacylation functions on one tRNAMin Guo, Yeeting E Chong, Kirk Beebe, et al.
Plos One|July 7, 2011
Dietary leucine--an environmental modifier of insulin resistance acting on multiple levels of metabolismYazmin Macotela, Brice Emanuelli, Anneli M Bång, et al.
Genetic Testing and Molecular Biomarkers|July 23, 2016
Metabolomic Profiling of Human Urine as a Screen for Multiple Inborn Errors of MetabolismAdam D Kennedy, Marcus J Miller, Kirk Beebe, et al.
Nature|August 15, 2006
Editing-defective tRNA synthetase causes protein misfolding and neurodegenerationJeong Woong Lee, Kirk Beebe, Leslie A Nangle, et al.
Plos One|June 8, 2010
alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic populationWalter E Gall, Kirk Beebe, Kay A Lawton, et al.
Biology Open|June 12, 2016
Metabolite profile of a mouse model of Charcot-Marie-Tooth type 2D neuropathy: implications for disease mechanisms and interventionsPreeti Bais, Kirk Beebe, Kathryn H Morelli, et al.
Molecular Metabolism|October 1, 2016
Defects in muscle branched-chain amino acid oxidation contribute to impaired lipid metabolismCarles Lerin, Allison B Goldfine, Tanner Boes, et al.
JCO Precision Oncology|September 4, 2025
Real-World Validation of the Purity Independent Subtyping of Tumors Classifier for Informing Therapy Selection in Pancreatic Ductal AdenocarcinomaStephane Wenric, Chithra Sangli, John Guittar, et al.
Cell Reports. Medicine|June 18, 2025
A phase 1/2a dose-finding study and biomarker assessment of oral lisavanbulin in patients with high-grade glioma or glioblastomaJuanita Suzanne Lopez, Simon Haefliger, Ruth Plummer, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Science (New York, N.Y.)|August 8, 2009
The C-Ala domain brings together editing and aminoacylation functions on one tRNAMin Guo, Yeeting E Chong, Kirk Beebe, et al.
Plos One|July 7, 2011
Dietary leucine--an environmental modifier of insulin resistance acting on multiple levels of metabolismYazmin Macotela, Brice Emanuelli, Anneli M Bång, et al.
Genetic Testing and Molecular Biomarkers|July 23, 2016
Metabolomic Profiling of Human Urine as a Screen for Multiple Inborn Errors of MetabolismAdam D Kennedy, Marcus J Miller, Kirk Beebe, et al.
Nature|August 15, 2006
Editing-defective tRNA synthetase causes protein misfolding and neurodegenerationJeong Woong Lee, Kirk Beebe, Leslie A Nangle, et al.
Plos One|June 8, 2010
alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic populationWalter E Gall, Kirk Beebe, Kay A Lawton, et al.
Biology Open|June 12, 2016
Metabolite profile of a mouse model of Charcot-Marie-Tooth type 2D neuropathy: implications for disease mechanisms and interventionsPreeti Bais, Kirk Beebe, Kathryn H Morelli, et al.
Molecular Metabolism|October 1, 2016
Defects in muscle branched-chain amino acid oxidation contribute to impaired lipid metabolismCarles Lerin, Allison B Goldfine, Tanner Boes, et al.
JCO Precision Oncology|September 4, 2025
Real-World Validation of the Purity Independent Subtyping of Tumors Classifier for Informing Therapy Selection in Pancreatic Ductal AdenocarcinomaStephane Wenric, Chithra Sangli, John Guittar, et al.
Cell Reports. Medicine|June 18, 2025
A phase 1/2a dose-finding study and biomarker assessment of oral lisavanbulin in patients with high-grade glioma or glioblastomaJuanita Suzanne Lopez, Simon Haefliger, Ruth Plummer, et al.
Pageof 2